PTPN2缺失在成人与儿童T-ALL中的临床与生物学特征
该研究在430例T-ALL患者(216例成人、214例儿童)中分析PTPN2缺失,检出率为8%,成人与儿童分别为9%和6%。PTPN2缺失与αβ谱系及TLX1失调显著相关,成人中与IL7R/JAK-STAT通路功能获得性改变及PHF6、WT1突变正相关,且与PTEN缺失互斥。
要点
- PTPN2缺失在成人与儿童T-ALL中检出率分别为9%和6%,总体为8%。
- PTPN2缺失与αβ谱系及TLX1失调显著相关,并与PTEN缺失互斥。
核心结论
- PTPN2缺失在成人与儿童T-ALL中发生率相当,并与αβ谱系、TLX1失调及IL7R/JAK-STAT通路改变相关。
- PTPN2缺失的儿童T-ALL糖皮质激素反应更高且生存有改善趋势,但成人中未观察到此趋势。
研究设计与样本
- 研究纳入430例T-ALL患者,包括216例成人和214例儿童,分别接受GRAALL03/05和FRALLE2000方案治疗。
- 采用多重连接依赖探针扩增(MLPA)检测PTPN2缺失。
主要发现
- PTPN2缺失总检出率为8%,成人9% vs 儿童6%。
- PTPN2缺失与αβ谱系和TLX1失调显著相关。
- 成人T-ALL中,PTPN2缺失与IL7R/JAK-STAT通路功能获得性改变及PHF6、WT1突变正相关。
- PTPN2缺失与PTEN缺失互斥。
关键数值与推荐
- PTPN2缺失检出率:总体8%,成人9%,儿童6%。
临床怎么用
- PTPN2缺失可作为T-ALL分子分型特征,与αβ谱系、TLX1失调及IL7R/JAK-STAT通路改变相关。
- 儿童PTPN2缺失T-ALL糖皮质激素反应较高,但生存改善仅为趋势,需进一步验证。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Protein tyrosine phosphatase nonreceptor type 2 (PTPN2) is a phosphatase known to be a tumor suppressor gene in T-cell acute lymphoblastic leukemia (T-ALL). Because the full clinicobiologic characteristics of PTPN2 loss remain poorly reported, we aimed to provide a comprehensive analysis of PTPN2 deletions within a cohort of 430 patients, including 216 adults and 214 children treated according to the GRAALL03/05 (#NCT00222027 and #NCT00327678) and the FRALLE2000 protocols, respectively. We used multiplex ligation-dependent probe amplification to identify an 8% incidence of PTPN2 deletion, which was comparable in adult (9%) and pediatric (6%) populations. PTPN2 deletions were significantly associated with an αβ lineage and TLX1 deregulation. Analysis of the mutational genotype of adult T-ALL revealed a positive correlation between PTPN2 deletions and gain-of-function alterations in the IL7R/JAK-STAT signaling pathway as well as PHF6 and WT1 mutations. Of note, PTPN2 and PTEN (phosphatase and tensin homolog) deletions were mutually exclusive. Regarding treatment response, PTPN2-deleted T-ALLs were associated with a higher glucocorticoid response and a trend for improved survival in children, but not in adults, with a 5-year cumulative incidence of relapse of 8% for PTPN2-deleted pediatric cases vs 26% (P = .177).
引用
- Alcantara M, Simonin M, Lhermitte L, et al. Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia. Blood Adv. 2019. PMID: 31270080. doi:10.1182/bloodadvances.2018028993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。